Veronica Sandoval is a Principal in the Patient Inclusion and Health Equity team in the Chief Diversity Office (CDO) at Genentech. Veronica’s policy and medical background, along with the personal and professional intersection of her Latino roots and health equity efforts, bring a rich perspective to Genentech’s ongoing work in health equity and inclusive research.
Veronica joined Roche-Genentech in 2018 as a Global Medical Collaboration Lead supporting the early clinical development program for autism. Prior to her role as Principal in the CDO, she supported the respiratory portfolio as a Medical Science Liaison. She has experience in health equity, medical affairs, thought leader development, patient engagement, and external partnerships. Therapeutic areas of expertise include ophthalmology, oncology, multiple sclerosis, immunology, asthma, inflammatory bowel disease, women’s health, autism spectrum disorder, idiopathic pulmonary fibrosis, and influenza. Veronica also practiced as an intellectual property litigation attorney focusing on complex patent litigation in the life sciences and pharmaceutical fields.
Veronica holds a Ph.D. in neuropharmacology from the University of Utah, a J.D. from Seattle University School of Law, and a B.A. in molecular and cell biology from the University of California, Berkeley.